about
Cryptosporidium pathogenicity and virulenceAntibiotics for the treatment of Cholera, Shigella and Cryptosporidium in childrenCryptosporidium taxonomy: recent advances and implications for public healthHIV-1 Tat protein suppresses cholangiocyte toll-like receptor 4 expression and defense against Cryptosporidium parvum.Localized glucose and water influx facilitates Cryptosporidium parvum cellular invasion by means of modulation of host-cell membrane protrusion.Cytoskeleton of apicomplexan parasitesModification of a rapid method for the identification of gene-specific polymorphisms in Cryptosporidium parvum and its application to clinical and epidemiological investigations.Probiotics for the control of parasites: an overview.Genotyping Cryptosporidium parvum with an hsp70 single-nucleotide polymorphism microarray.Effect of particles on the recovery of cryptosporidium oocysts from source water samples of various turbidities.Molecular characterization of isolates of waterborne Cryptosporidium spp. collected during an outbreak of gastroenteritis in South Burgundy, France.A statewide outbreak of Cryptosporidium and its association with the distribution of public swimming pools.Comparison of diagnostic techniques for the detection of Cryptosporidium oocysts in animal samples.The human immunodeficiency virus type 1 tat protein enhances Cryptosporidium parvum-induced apoptosis in cholangiocytes via a Fas ligand-dependent mechanism.Isolation and Proteomic Analysis of Rhoptry-Enriched Fractions from Cryptosporidium parvum.A Bibliometric and Trend Analysis on the Water-Related Risk Assessment Studies for Cryptosporidium Pathogen.Cryptosporidium parvum infects human cholangiocytes via sphingolipid-enriched membrane microdomains.Seasonality of cryptosporidiosis: A meta-analysis approach.Comparative sensitivity of PCR primer sets for detection of Cryptosporidium parvumCdc42 and the actin-related protein/neural Wiskott-Aldrich syndrome protein network mediate cellular invasion by Cryptosporidium parvum.Temporal and spatial distribution of human cryptosporidiosis in the west of Ireland 2004-2007.Apical organelle discharge by Cryptosporidium parvum is temperature, cytoskeleton, and intracellular calcium dependent and required for host cell invasion.Pulmonary cryptosporidiosis in an immunocompetent host treated successfully with nitazoxanideSpecies-specific, nested PCR-restriction fragment length polymorphism detection of single Cryptosporidium parvum oocysts.Cryptosporidium parvum infection requires host cell actin polymerization.Cryptosporidium parvum mixed genotypes detected by PCR-restriction fragment length polymorphism analysis.Host cell fate on Cryptosporidium parvum egress from MDCK cells.A Sensitive and Specific PCR Based Method for Identification of Cryptosporidium Sp. Using New Primers from 18S Ribosomal RNA.Cooperative role of macrophages and neutrophils in host Antiprotozoan resistance in mice acutely infected with Cryptosporidium parvum.Low incidence of concurrent enteric infection associated with sporadic and outbreak-related human cryptosporidiosis in Northern Ireland.Treatment of giardiasis.
P2860
Q26823336-36981377-B03A-40F1-B653-BA5F3E38F891Q27009922-0C66E96F-FF66-48FE-9C75-1AD01CD7A312Q28776364-CA022CDF-45C7-4280-A7FB-9D54FEBB50F3Q30436450-B33E18E1-0293-49FC-AACD-0B833B86627DQ33772004-F3F2F5B6-B71E-4332-8A0A-61C5499E3366Q33969437-A179ED28-0836-485E-ADF0-25FA79359C28Q33990870-CF3A13A9-FFA8-49AA-A14F-09279648D998Q34038407-A4453646-93FD-4D10-A522-1D8688610C88Q34052927-67455C27-8C83-4DCD-A74F-2EB561844ED9Q34992858-4F867598-5ECC-4995-965D-205538CD68CFQ35027882-AC252FBD-BCCE-44F3-8A1E-F1D7E7EB2D28Q35147511-5DEE4715-E581-4E29-9A57-516179ED7E71Q35523897-ACC003DE-72F2-46A4-8449-EC90CCA9C554Q35689260-C2CDB22F-61F1-44B2-8ED5-C64E1BCAC0DAQ36282158-228162E8-32BF-461F-9B98-5223E43E196FQ36327190-A605B09F-9429-403A-AC05-9288C6459D02Q36343192-2F508D0D-037A-473D-9873-D24D310AF635Q37319327-B25D4434-D814-4C56-8643-E9512F2E0151Q37327842-43FD31CF-357B-40A4-817C-2865001A67E6Q37427560-104F8724-DAA2-42FA-A81C-DF2CA5B58EE7Q37463064-19753AA3-AEB6-4D98-A59A-B90321598285Q37624192-DD53A098-06CD-4800-8D13-D39851253A6FQ38341506-2D9D661D-9E83-41DD-8B31-C8E498233EADQ39491269-90DDB1CB-1EAB-4DD0-A547-E65FB7A075C0Q39522195-B6D5158F-D668-4E8A-A012-76D1B4680619Q39649316-7668C231-BFA4-4ED3-90E7-3FBAD305E0BEQ39863728-E6145E64-D272-4973-A407-5BA85A8EC78DQ41135620-77AE29D4-4D7B-4951-B98E-70BCDE21EE87Q41342563-3C13EEA4-6E7B-40B3-8245-88A9F58E3189Q42768976-BC84D3ED-E995-4447-A0C8-46EBDB5DCDB7Q55034504-9A2C2E66-5ED0-4CA1-89C7-99AE96CDF4FD
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
New insights into human cryptosporidiosis.
@ast
New insights into human cryptosporidiosis.
@en
type
label
New insights into human cryptosporidiosis.
@ast
New insights into human cryptosporidiosis.
@en
prefLabel
New insights into human cryptosporidiosis.
@ast
New insights into human cryptosporidiosis.
@en
P2860
P1476
New insights into human cryptosporidiosis.
@en
P2093
P2860
P304
P407
P577
1999-10-01T00:00:00Z